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The coronavirus disease 2019 (COVID-19) is a once-in-a-century pandemic, and the virus, the severe 
acute respiratory syndrome coronavirus 2 or SARS-CoV-2, has infected more than 180 million people 
and claimed almost 4 million lives worldwide (as of 5 July 2021) since the first case was reported in 
Wuhan, China, on 31 December 2019. The China National Center for Bioinformation (CNCB) responded 
promptly and launched the 2019 Novel Coronavirus Resource (2019nCoVR; 
https://ngdc.cncb.ac.cn/ncov/) in January 2020 for rapid release and public sharing of SARS-CoV-2 
genomic data and analysis tools (Figure 1A).
1,2
 The 2019nCoVR has quickly grown to be one of the most 












variation and conduct genomic analysis and annotation.
3
 The 2019nCoVR provides valuable information 
that helps understand molecular evolution and epidemiological dynamics of SARS-CoV-2, which can 
help inform decisions about controlling the spread of the virus. In this commentary, we highlight 
important features of the 2019nCoVR related to SARS-CoV-2 surveillance and comment on areas that 
will benefit future improvement of the resource. 
Genomic sequence data are of paramount importance in epidemiology and play a vital role in 
understanding the transmission and evolution of SARS-CoV-2 and developing COVID-19 diagnostics, 
vaccines, and therapeutics. The release of the first genome of SARS-CoV-2 (10 January 2020) has 
enabled the development of vaccines and molecular testing tools. Genomic surveillance has been 
providing insights into regional and global establishment and lineage dynamics of the COVID-19 
epidemic.
4
 In addition to accepting direct submission, the 2019nCoVR incorporates sequence information 
from other resources, including GISAID (https://www.gisaid.org/) and NCBI GenBank 
(https://www.ncbi.nlm.nih.gov/sars-cov-2/). Whereas only a few sequences were available at the end of 
February 2020, the 2019nCoVR has collected data for more than 2 million complete genome sequences 
from 167 countries and regions by the end of June 2021, indicating an unprecedented speed in sequencing 
SARS-CoV-2 genomes. While several other major SARS-CoV-2 genomic resources exist as listed at the 
NU-COVID, http://bioinfolab.unl.edu/emlab/nucovid/, it should be noted that the 2019nCoVR has 
developed a set of standards for genomic data integrity and quality control.
3
 
The 2019nCoVR offers multiple ways to explore and visualize SARS-CoV-2 genome variations. 
Based on sequence alignment and variation identification against the reference genome (MN908947.3), 
the 2019nCoVR identified and annotated over 28,900 nucleotide mutations that correspond to 21,324 
amino acid changes (5 July 2021), shown in the histograms of isolate number versus the number of 
nucleotide or amino acid substitutions. Genomic variations can be easily inquired with multiple searching 












SARS-CoV-2 variations can be inspected through the heat maps across the time and countries, with many 
filter options including variant frequency, genes/regions, mutation types, and transcriptional regulation 
sites. For example, the variation dynamic curve of the D614G variant (S protein; nucleotide position: 
23,403) demonstrated this variant emerged in February and early March 2020 and gradually became 
dominant, particularly in Europe and North America (Figure 1B), likely attributed to higher 
transmissibility of this variant. The comparison of variation dynamic curves clearly showed a difference 
in the accumulation of this mutation among countries. The most updated data can be obtained from: 
https://bigd.big.ac.cn/ncov/variation/annotation/variant/23403?lang=en. 
The 2019nCoVR adopts the Pango lineage assignment established by Rambaut et al.
5
 for all 
sequences in the database. In the Lineage Browser, the distributions of sampling dates and countries, as 
well as variants for each lineage, are summarized in interactive charts and tables. For example, the 
sublineage B.1.1.7 (WHO label: Alpha), the lineage emerging and extensively circulating in the UK in 
December 2020, is shown to have spread worldwide and peaked at the end of March 2021, then 
diminished dramatically by the end of June 2021 (Figure 1C). In contrast, the recently emerging Delta 
variant (Pango lineage B.1.617.2) shows a very different pattern in its temporal dynamics, i.e., the number 
of sampled viral isolates increasing much later (Figure 1D). Users, including virologists and 
policymakers, can also examine the evolutionary relationships and dynamics of SARS-CoV-2 by 
exploring phylogenetic trees and haplotype networks. In the Viral Haplotype Network, for example, the 
progression of the viral haplotype networks can be traced temporally as well as spatially using animation.  
The 2019nCoVR has developed and made available a number of COVID-19 related resources and 
tools. It provides pipelines and tools for SARS-CoV-2 genome assembly, variation identification, variant 
and genome annotations. De novo Assembly allows assembling raw sequencing reads, estimating 
sequencing depth, and comparing the assembled contigs to the SARS-CoV-2 reference genome. The 












and Indels, and annotate them. With the Variant Annotation tool, the users can perform functional 
annotation of the mutations and display mutation patterns and effects. The COVID-19 pandemic has 
caught the massive attention of the scientific communities, and the number of scientific publications has 
been increasing exponentially. The literature resource in the 2019nCoVR has achieved over one hundred 
thousand entries, including research articles, preprints, letters, editorials, etc. 
With many useful resources and tools, navigating throughout the menus and submenus to discover all 
contents available in the 2019nCoVR is at times tedious. Providing easy-to-follow user manuals and 
tutorials for many tools and resources and cross-linking information from different resources could 
enhance user experience with the 2019nCoVR. There are many appealing visual presentations of SARS-
CoV-2 statistics. However, image rendering sometimes takes a long loading time (e.g., haplotype network 
dynamics for all lineages) or does not refresh promptly (e.g., linage browse), dampening the user 
experience. This might be an area for future improvement. It would also be helpful to make the images 
downloadable and of high resolution suitable for publication. While incorporating clinical data into the 
2019nCoVR resource is a welcome feature, only a limited number of records were available in an earlier 
version. At the time of this review, the link to the Clinic and CT Image seems to be broken. For the 
lineage classification, the 2019nCoVR only uses the Pango lineage assignment. It could be helpful if it is 
cross-referenced with other viral assignments, such as those from WHO and Nextstrain 
(https://nextstrain.org/). Overall, the 2019nCoVR is a comprehensive and integrated SARS-CoV-2 
genomic analysis platform, with many useful and practical features for analysis and annotation of SARS-
CoV-2 genomes and COVID-19 epidemiological dynamics. It engages more communities through rapid 
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Figure 1. Example screenshots of the 2019nCoVR. (A) The 2019nCoVR home page 
(https://ngdc.cncb.ac.cn/ncov/?lang=en) showing available resources and tools. (B) Variation dynamic 
curves of the D614G variant (genomic position 23,403) in the spike protein circulating among countries. 
(C) Sample distribution across different dates for the lineage B.1.1.7 (Alpha variant). (D) Sample 
distribution across different dates for the lineage B.1.617.2 (Delta variant). The images are slightly 
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